Compounds > silybin
Page last updated: 2024-08-23

silybin and Adenoma

silybin has been researched along with Adenoma in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Cassarino, MF; Lasio, G; Losa, M; Pecori Giraldi, F; Sesta, A1
Reincke, M; Theodoropoulou, M1
Huso, DL; Karim, BO; Liu, G; Rhee, KJ; Zheng, D1
Buchfelder, M; Freiburger, L; Hausch, F; Kozany, C; Paez-Pereda, M; Riebold, M; Sattler, M; Stalla, GK1
Lubet, RA; Tan, Q; Wang, Y; Yan, Y; You, M1
Brown, K; Gescher, AJ; Greaves, P; Marsden, DA; Patel, K; Steward, WP; Verschoyle, RD1

Reviews

1 review(s) available for silybin and Adenoma

ArticleYear
Tumor-Directed Therapeutic Targets in Cushing Disease.
    The Journal of clinical endocrinology and metabolism, 2019, 03-01, Volume: 104, Issue:3

    Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Antineoplastic Agents; Cabergoline; Clinical Trials as Topic; Corticotrophs; Humans; Pituitary ACTH Hypersecretion; Roscovitine; Silybin; Somatostatin; Treatment Outcome; Tretinoin

2019

Other Studies

5 other study(ies) available for silybin and Adenoma

ArticleYear
Silibinin, an HSP90 Inhibitor, on Human ACTH-Secreting Adenomas.
    Neuroendocrinology, 2023, Volume: 113, Issue:6

    Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adrenocorticotropic Hormone; Antineoplastic Agents; Dexamethasone; Humans; Pituitary ACTH Hypersecretion; Pro-Opiomelanocortin; Receptors, Glucocorticoid; Silybin

2023
Chemoprevention utility of silibinin and Cdk4 pathway inhibition in Apc(-/+) mice.
    BMC cancer, 2013, Mar-27, Volume: 13

    Topics: Adenoma; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemoprevention; Colorectal Neoplasms; Cyclin D1; Cyclin-Dependent Kinase 4; Disease Models, Animal; Female; Genes, APC; Humans; Ki-67 Antigen; Mice; Mice, Knockout; Retinoblastoma Protein; Signal Transduction; Silybin; Silymarin

2013
A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease.
    Nature medicine, 2015, Volume: 21, Issue:3

    Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Allografts; Animals; Disease Models, Animal; Drug Resistance; Gene Expression Regulation, Neoplastic; HSP90 Heat-Shock Proteins; Humans; Mice; Pituitary ACTH Hypersecretion; Protein Folding; Receptors, Glucocorticoid; Silybin; Silymarin

2015
Efficacy of deguelin and silibinin on benzo(a)pyrene-induced lung tumorigenesis in A/J mice.
    Neoplasia (New York, N.Y.), 2005, Volume: 7, Issue:12

    Topics: Adenoma; Administration, Oral; Animals; Benzo(a)pyrene; Disease Models, Animal; Lung Neoplasms; Mice; Mice, Inbred A; Rotenone; Silybin; Silybum marianum; Silymarin

2005
Evaluation of the cancer chemopreventive efficacy of silibinin in genetic mouse models of prostate and intestinal carcinogenesis: relationship with silibinin levels.
    European journal of cancer (Oxford, England : 1990), 2008, Volume: 44, Issue:6

    Topics: Adenoma; Animals; Anticarcinogenic Agents; Body Weight; Chromatography, High Pressure Liquid; Drug Evaluation; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Intestinal Neoplasms; Male; Mice; Mice, Inbred C57BL; Phosphatidylcholines; Prostatic Neoplasms; Silybin; Silymarin

2008